University of Florida

References

Publications

Hartzema AG, Winterstein AG, Johns T, De Leon J, Baily W, McDonald K, Pannell R.  Planning for Pharmacy Health Informaton technology (pHIT) in Critical Access Hospitals.  America Journal of Health System Pharmacy (in print)

Shuster J, Winterstein AG. Interrupted time series was accurate in showing improvement in medication errors. J Clin Epidem 2006 (in print)

Beaver TM, Winterstein AG, Shuster JJ, Gerhard T, Martin T, Alexander JA, Johnson RJ, Ejaz A, Hartzema AG. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 2006;29:18-24

Winterstein AG , Hartzema AG, Johns JE, DeLeon JM, McDonald K, Henshaw Z, Pannell R. Medication Safety Infrastructure in critical access hospitals in Florida. American Journal of Health Systems Pharmacy 2006; 63(5):442-450

Pasanen AL, Edwards E, Annis LG, Guyer LK, Winterstein AG. The Influence of Age on Knowledge and Medication Usage by Persons Attending Rural North Florida Clinics. Florida Public Health Review (in print)

Gerhard T, Zineh I, Winterstein AG, Hartzema AG. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Pharmacother 2006;26(1):34–43

Winterstein AG , Hartzema AG. Pharmacy-specific quality indicators for asthma therapy. Research in Social and Administrative Pharmacy. 2005;1:430-445

Smith WD, Winterstein AG, Johns TE, Rosenberg EI, Sauer BC. Causes of Hyper- and Hypoglycemia in adult medical and surgical patients. Am J Health Syst Pharm 2005;62 714-719

Winterstein AG , Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R. Nature and causes of clinically significant medication errors in hospitals: Results of a unique multidisciplinary prospective data collection method. Am J Health Syst Pharm. 2004 Sep 15;61(18):1908-16

Kanjanarat P, Winterstein AG, Johns TE, Gonzalez-Rothi R, Hatton RC, Segal R, The nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacists 2003;60:1750-9

Winterstein AG , Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. High-priority preventable adverse drug events identified from a hospital ADR report database. Am J Health-Syst Pharm 2002;59:1742-9

Brushwood DB, Winterstein AG. Manufacturer Warnings of System-Related Medication Errors. American Journal of Health-Systems Pharmacy 2002;59:1110-1112

Winterstein AG , Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Annals of Pharmacotherapy 2002;36:1238-1248

Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjar B, Grundberger E, Gustafsson T, Henman M, Herborg H, Hughes C, McElnay J, Magner M, van Mil F, Schaefer M, Silva S, Sondergaard B, Sturgess I, Tromp D, Vivero L, Winterstein A, on behalf of the Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care – a multi-center study in seven European countries. Drugs & Aging 2001;18(1):63-77

Winterstein AG , Jopp R, Schaefer M. Aeltere multimorbide Patienten werden in Apotheken gut betreut – Ergebnisse der OMA Studie Teil 1. [Pharmaceutical Care for elderly multimorbide patients – results of the OMA study, part 1] Pharm Ztg 2001;146(11): 833 - 841

Winterstein AG , Jopp R, Schaefer M. Gesundheitsbezogene Lebensqualität als wichtiges Zielkriterium [Health-related quality of life as important health outcome] Pharm Ztg. 2001;146 (12):936 - 942

Winterstein AG , Jopp R, Schaefer M. Patienten profitieren von der Pharmazeutischen Betreuung [Patient benefit from pharmaceutical care] Pharm Ztg. 2001;146 (13):1024-1033

Schaefer M., Bergmann KC., Schulz M., Mühlbauer K., Müller-Jaeger A., Kahmen U.: Pharmazeutische Betreuung – Arzt und Apotheker auf dem Weg in die Zukunft. [Pharmaceutical Care – physician and pharmacist on their way to future], Münch Med Wschr. 1998; 140(23): 343-345.

Müller-Jaeger A. , Pharmaceutical care – nutzbringende Innovation für die Gesundheitsversorgung, [Pharmaceutical Care: beneficial innovation in health care] Apothekenpraxis (1998)

Belgardt C., Krishnan HS., Müller-Jaeger A., Räuscher E.:, Qualität der Pharmakotherapie sichern. [Assure quality of pharmacotherapy] Pharm Ztg. 1997; 142(3): 152- 154

Belgardt C, Krishnan HS, Müller-Jaeger A, Räuscher E. Social pharmacy goes west. Pharm Ztg. 1997; 142 (1/2): 38-40

Müller-Jaeger A ., Erkennen wie uns andere sehen. [Recognize how others see us.] Pharm Ztg. 1997; 142(7): 527-531

Van Mil JWF., Müller-Jaeger A., Schaefer M., Tromp Th.: Pharmazeutische Betreuung: Fortschritte und Erfahrungen in den Niederlanden. [Pharmaceutical Care: progress and experiences in the Netherlands] Pharm Ztg. (1997) 142(25): 2543-49

Müller-Jaeger A. , Schaefer M., Pharmaceutical Care in der Praxis: Startschuss für Pilotprojekt in Berlin. [Pharmaceutical Care in practice: go-ahead for a pilot project in Berlin] Pharm Ztg. 1996; 141(30): 2739-2748

Schaefer M., Müller-Jaeger A., Belgardt C.: Berlin startet bundesweit erste Studie. [Pharmaceutical Care- Berlin starts first national study] Pharm Ztg. 1996; 33(141): 44-45

(Almut Winterstein, formerly Almut Müller-Jaeger)

Book Chapters

Winterstein AG , Pharmakooekonomie [Pharmaco-economics] (chapter 7), in Weinzierl S (ed.) Praxis der Arzneimittelinformation [Practice of Drug Information], Govi Verlag, Eschborn, 2002